(Q48756180)

15 February 2018

title

Stimulation of pulmonary immune responses by the TLR2/6 agonist MALP-2 and effect on melanoma metastasis to the lung. (English)

1 reference

15 February 2018

0 references

Michael P Schön

2

0 references

author name string

Tillmann Schill

1

1 reference

15 February 2018

Nadin Pletz

3

1 reference

15 February 2018

Steffen Emmert

4

1 reference

15 February 2018

Margarete Schön

5

1 reference

15 February 2018

publication date

1 November 2011

1 reference

15 February 2018

published in

Experimental Dermatology

1 reference

15 February 2018

volume

21

1 reference

15 February 2018

issue

2

1 reference

15 February 2018

page(s)

91-98

1 reference

15 February 2018

Systemic therapy for metastatic malignant melanoma--from deeply disappointing to bright future?

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Systemic chemotherapy in the treatment of malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Immunotherapy of distant metastatic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Cancer immunotherapy: a treatment for the masses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Imiquimod, a topical immune response modifier, in the treatment of cutaneous metastases of malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

TLR7 and TLR8 as targets in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Toll-like receptor 9 (TLR9) agonists in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Tumour suppression induced by the macrophage activating lipopeptide MALP-2 in an ultrasound guided pancreatic carcinoma mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Intratracheal macrophage-activating lipopeptide-2 reduces metastasis in the rat lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Intratumoural injection of the toll-like receptor-2/6 agonist 'macrophage-activating lipopeptide-2' in patients with pancreatic carcinoma: a phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and -independent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Discrimination of bacterial lipoproteins by Toll-like receptor 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Activation of nuclear factor-kappaB in macrophages by mycoplasmal lipopeptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

A Mycoplasma fermentans-derived synthetic lipopeptide induces AP-1 and NF-kappaB activity and cytokine secretion in macrophages via the activation of mitogen-activated protein kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Recruitment of lymphocytes and dendritic cells from the blood to the bronchoalveolar space and the draining lymph nodes after a single intrabronchial application of the lipopeptide MALP-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

The Toll-like receptor ligand MALP-2 stimulates dendritic cell maturation and modulates proteasome composition and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Improved intranasal immunization with live-attenuated measles virus after co-inoculation of the lipopeptide MALP-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Synthetic mycoplasma-derived lipopeptide MALP-2 induces maturation and function of dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

In vivo effects of a synthetic 2-kilodalton macrophage-activating lipopeptide of Mycoplasma fermentans after pulmonary application

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

TLR2/6 stimulation of the rat lung: effects on lymphocyte subsets, natural killer cells and dendritic cells in different parts of the air-conducting compartments and at different ages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Expression of 38-kD cell-surface glycoprotein in transformed human keratinocyte cell lines, basal cell carcinomas, and epithelial germs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Flow cytometric identification of murine neutrophils and monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Inhibition of platelet GPIb alpha and promotion of melanoma metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Toll-like receptors on tumor cells facilitate evasion of immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Integrin adhesion receptors in tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Deadly allies: the fatal interplay between platelets and metastasizing cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

NK cells rapidly remove B16F10 tumor cells in a perforin and interferon-gamma independent manner in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Kinetics of the early recruitment of leukocyte subsets at the sites of tumor cells in the lungs: natural killer (NK) cells rapidly attract monocytes but not lymphocytes in the surveillance of micrometastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

The macrophage-activating lipopeptide-2 accelerates wound healing in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Bacillus Calmette-Guerin immunotherapy for urothelial carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Oxidative burst of neutrophils against melanoma B16-F10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Nanoparticle-delivered multimeric soluble CD40L DNA combined with Toll-Like Receptor agonists as a treatment for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Tumour immunity: effector response to tumour and role of the microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

ICAM-1 and LFA-1 play critical roles in LPS-induced neutrophil recruitment into the alveolar space

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Stepping out of the flow: capillary extravasation in cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

High affinity interaction of integrin alpha4beta1 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances migration of human melanoma cells across activated endothelial cell layers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Activation of Toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2011.01386.X

10.1111/J.1600-0625.2011.01386.X

21 January 2018

Identifiers

DOI

1 reference

15 February 2018

PubMed ID

22044500

1 reference

15 February 2018